The Royal College of Physicians, 11 St Andrews Place, Regent's Park, London NW1 4LE, England
Please contact the event's organizers for more information
This conference is jointly sponsored by the Karolinska Institutet (Sweden) and the Alzheimer's Drug Discovery Foundation, and is a unique venue for addressing issues related to the economic evaluation of drug treatments for Alzheimer's disease.
ICAD 2011 is sponsored by the Alzheimer's Association and some preliminary information is currently posted at www.alz.org/icad/icad_paris.asp . According to the Alzheimer's Association, ICAD's aim is to foster interdisciplinary interactions among healthcare, research, clinical and administrative professionals concerned with aging and Alzheimer's disease. In addition to core plenary sessions, oral, symposia and poster sessions will be presented to encourage and stimulate diverse viewpoints in research, treatment and care.
Continuing Education Credits:
Alzheimer's Association ICAD 2011 Conference Team Tel: 312-335-5790
Hyatt Regency Jersey City, 2 Exchange Place, Jersey City, NJ 07302
Please check the event's website for further details
This conference is presented by the Alzheimer's Drug Discovery Foundation and will bring together academic and industry researchers to accelerate the development of innovative drugs for the treatment of Alzheimer's disease and related dementias.
It is geared towards scientists, business development and licensing professionals, health management professionals, and venture capitalists.
Dr. Jerome and Judith D. Tamkin Auditorium, Ronald Reagan UCLA Medical Center (B Level), 757 Westwood Plaza, University of California, Los Angeles, CA 90095
$350.00 for physicians/faculty; $200 for allied-health practitioners/trainees (residents, post-doctoral fellows, graduate & medical students). Fees will be increased by $100 after March 31, 2010
This 3-day symposium is sponsored by the Department of Pathology & Laboratory Medicine and the Office of Continuing Medical Education of the David Geffen School of Medicine at University of California at Los Angeles.
Molecular/cellular pathogenesis, clinical markers, inheritance, biochemical and neuroimaging biomarkers, treatment strategies and the role of dementia in CAA will be discussed.
More information may be found on the attached symposium brochure.
Institute of Engineering and Technology, 2 Savoy Place, London WC2R 0BL, England
One-Day Rate (GBP 450.00); Two-Day Rate (GBP 763.75 for Consultants and GPs; GBP 587.50 for Others)
This professional conference is organized by the British Journal of Hospital Medicine and will provide attendees with an update on clinical, research, organizational and policy developments in the field of dementia in the United Kingdom.
More information regarding the program is attached.
Continuing Education Credits:
12 CPD Points
Mark Ellen Group
Freepost BFH 1337
London SE24 9BR
Tel: 0207 733 8174
Email: conferences [ at ] markallengroup [dot] com
Centre Convencions Internacional Barcelona, Rambla Prim, 1-17, 08019 Barcelona, Spain
Please visit the event's website for more information
This multi-disciplinary conference will feature new discoveries in etiology, neurobiology, diagnosis, imaging and treatment for Alzheimer's, Parkinson's and related neurodegenerative diseases. Young investigators are especially encouraged to attend.
The symposium will be sponsored by the Southern Illinois University School of Medicine, the University of Geneva Medical School, the Geneva University Hospitals (Department of Rehabilitation and Geriatrics) and the Karolinska Institute. New therapeutic targets and outcomes of clinical trials will be discussed.
International Conference Center, 17 rue de Varembe, CP13, CH-1211, Geneva 20, Switzerland
US $880 (through Jan 22, 2010); US $980 (after Jan 22, 2010). Student Fees: US $180 (through Jan 22, 2010); US $280 (after Jan 22, 2010)
This bi-annual symposium is organized by Southern Illinois University School of Medicine, University of Geneva Medical School, and Geneva University Hospitals (Department of Rehabilitation and Geriatrics), and is the only international meeting focused on the pharmacological therapy of Alzheimer's disease.
Symposium themes include: drug development at different preclinical and clinical stages, results of clinical trials, and pharmaco-economics implications.
The event is targeted towards neurologists, psychiatrists, geriatricians and caregivers of individuals with Alzheimer's disease.
More information regarding this event may be found at www.ad-springfield.com and on the attached event brochure.